Reilly Financial Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Reilly Financial Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,500	Closed	-$76K	–	1414
2014 Q4	$76K	Hold	4,500	–	–	0.02%	215
2014 Q3	$54K	Sell	4,500 -13,000	-74%	-$88.8K	0.01%	245
2014 Q2	$100K	Hold	17,500	–	–	0.02%	185
2014 Q1	$64K	Buy	+17,500	New	+$66.7K	0.02%	241

Reilly Financial Advisors's AVNR Position: Q1 2015 in Review

Reilly Financial Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 4,500 shares — an estimated $76K sold.

Reilly Financial Advisors first reported a position in AVNR in Q1 2014 and held it in 4 quarters. The position peaked at $100K in Q2 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Reilly Financial Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Reilly Financial Advisors sold 4,500 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $76K.
Reilly Financial Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q1 2014 and held it in 4 quarters.
Reilly Financial Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $100K in Q2 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Reilly Financial Advisors's 13F filing for Q1 2015, filed 15 May 2015.